Status:
UNKNOWN
Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19)
Lead Sponsor:
Laval University
Conditions:
Coronavirus
Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There is a high risk of transmission of COVID-19 to healthcare workers. In a recent cohort, 29% of the patients hospitalized were healthcare workers. Among the WHO's primary strategic objectives for t...
Eligibility Criteria
Inclusion
- Age\> 18 years old
- patients with acute respiratory failure related to suspected community acquired pneumonia (viral and non viral) requiring oxygen therapy \< 6 L/min (or FiO2\< 0.50) (to maintain SpO2 between 90 and 94% SpO2) without criteria for immediate intubation or ICU transfer.
- Patients hospital admission \< 72 hours
Exclusion
- shock state,
- no SpO2 signal available,
- patient agitation,
- pH \< 7.30 (if blood gas available)
- PaCO2 \> 50 mmHg, (if blood gas available) or chronic hypercapnia history
- Non invasive respiratory support (NIV, High flow Nasal Therapy (HFNT)) at study inclusion
- Withdrawal of life support or palliation as the goal of care
- patients' or next of kin refusal to participate to the study
Key Trial Info
Start Date :
April 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2021
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT04320056
Start Date
April 20 2020
End Date
October 31 2021
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval
Québec, Canada, G1V4G5